Antoni Chan

From Risk to Treatment: Clinical Updates in Osteoporosis Management

Karam Alchi, Antoni Chan

gb (code pays fourni par la source)

Explainable machine learning-based prediction of psoriatic arthritis flares using heterogenous real-world data for personalised patient care

Pradip Moon, Weizi Li, Antoni Chan, Bing Wang et autres

Psoriatic arthritis (PsA) is a chronic inflammatory disease characterised by unpredictable flare-ups that are difficult to forecast, particularly in patients without an acute phase response. In this paper, we propose and apply an explainable, multimodal machine learning framework that jointly leverages structured …

gb (code pays fourni par la source)

Consensus Statement on Optimisation of Patient Management Following Hospitalisation for Acute Heart Failure—Guidance of Therapy

Andrew Sindone, Carmine G. De Pasquale, Goh Lee Gan, John Amerena et autres

au (code pays fourni par la source)

Updates from the European Alliance of Associations for Rheumatology (EULAR) 2025 Congress

Antoni Chan

THE European Alliance of Associations for Rheumatology (EULAR) 2025Congress was held in Barcelona, Spain, from the 11 th -14 th June.Important abstracts covering updates in axial spondyloarthritis (axSpA), lupus nephritis (LN), psoriatic arthritis (PsA), and rheumatoid arthritis (RA) were presented over the …

gb (code pays fourni par la source)

Five years of the Digital Rheumatology Network: insights and future directions

Antoni Chan, Johannes Knitza, Vincenzo Venerito, Jutta Richter et autres

Objectives: To outline Digital Rheumatology Network (DRN)'s activities, trends, and achievements over the past 5 years and to highlight concrete implementations and future directions in digital rheumatology. Methods: This article reviews the evolution of DRN activities, such as podcasts, webinars, research awards, …

gb, de, it, ch, nl (code pays fourni par la source)

ABS0421 UNRAVELLING EARLY AXIAL SPONDYLOARTHRITIS: DISTINCT CLINICAL AND DEMOGRAPHIC PROFILES OF EARLY VERSUS LATE DISEASE

Antoni Chan, K. Rigler

Background: Early recognition of axial spondyloarthritis (axSpA) is critical for improving outcomes. Emerging evidence suggests distinct differences between patients presenting with early axSpA (≤2 years symptom duration) and those with late axSpA (>2 years symptom duration), emphasizing the importance of tailored management …

gb (code pays fourni par la source)

Corrigendum to “Multi-stage multimodal fusion network with language models and uncertainty evaluation for early risk stratification in rheumatic and musculoskeletal diseases” [Information Fusion, Volume 120 (2025) 103068]

Bing Wang, Weizi Li, Anthony Bradlow, A. Watt et autres

gb (code pays fourni par la source)

Executive Summary: The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs

Sizheng Steven Zhao, Stephanie R Harrison, Ben Thompson, Max Yates et autres

Background and rationale for guideline development: Axial spondyloarthritis (axSpA) is a chronic inflammatory condition that predominantly affects the spine and sacroiliac joints [1]. It can also involve peripheral joints and entheses, and extra-musculoskeletal manifestations (EMMs) such as acute anterior uveitis, psoriasis and …

gb, it, us, ca (code pays fourni par la source)

The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs

Sizheng Steven Zhao, Stephanie R Harrison, Ben Thompson, Max Yates et autres

Axial spondyloarthritis (axSpA) is a chronic inflammatory condition that predominantly affects the spine and sacroiliac joints [1]. It can also involve peripheral joints and entheses, and extra-musculoskeletal manifestations (EMMs) such as acute anterior uveitis, psoriasis and IBD. Symptoms of axSpA typically begin …

gb, it, us, ca (code pays fourni par la source)

Assessing Disease Activity in Axial Spondyloarthritis: Finding the Balance Between the Bath Ankylosing Spondylitis Disease Activity Index and Axial Spondyloarthritis Disease Activity Score

Antoni Chan

Axial spondyloarthritis (axSpA) is a chronic inflammatory condition that significantly affects patients’ quality of life.1 Accurate assessment of disease activity is critical for both clinical decision making and evaluating treatment response. The 2 most widely used measures of disease activity, the Bath …

gb (code pays fourni par la source)

OA13 Preliminary results from the National Axial Spondyloarthritis Society time to diagnosis audit: two years on

Thomas A Ingram, Joe Eddison, Antoni Chan, Marian Chan et autres

Abstract Background/Aims Time to diagnosis (TTD) is a worldwide problem in axial spondyloarthritis (axial SpA), with the UK faring worse than many other countries. Extended delays are associated with functional decline, poorer psychological well-being and higher healthcare costs. In June 2021, the …

ca, gb (code pays fourni par la source)

P117 Remote monitoring of rheumatoid arthritis using RAPID3 to support patient-initiated follow up

Antoni Chan

Abstract Background/Aims The management of rheumatoid arthritis (RA) requires continuous disease activity monitoring to guide treatment. DAS28-CRP and RAPID3 (Routine Assessment of Patient Index Data 3) are two outcomes measures used in RA. The RAPID3 is done without the need for physician …

gb (code pays fourni par la source)